Covered recipient · General Payments record
NISHA R VARGHESE
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2018–2024
$2,479.96
- Reported across 161 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $249.21 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $60.51 | 4 |
| ABBVIE INC. | $29.49 | 2 |
| Amneal Pharmaceuticals LLC | $28.60 | 2 |
| Lilly USA, LLC | $27.56 | 2 |
| BETA BIONICS, INC. | $25.51 | 2 |
| Alexion Pharmaceuticals, Inc. | $18.32 | 1 |
| DEXCOM, INC. | $16.84 | 1 |
| Radius Health, Inc. | $15.71 | 1 |
| Abbott Laboratories | $13.37 | 1 |
| Corcept Therapeutics | $13.30 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $13.37 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125058483 | CMS |
| ABBVIE INC. | $14.99 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106272032 | CMS |
| ABBVIE INC. | $14.50 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106272034 | CMS |
| Alexion Pharmaceuticals, Inc. | $18.32 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1093889569 | CMS |
| Amneal Pharmaceuticals LLC | $14.27 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139204582 | CMS |
| Amneal Pharmaceuticals LLC | $14.33 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139204584 | CMS |
| BETA BIONICS, INC. | $11.52 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087877315 | CMS |
| BETA BIONICS, INC. | $13.99 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087885831 | CMS |
| Corcept Therapeutics | $13.30 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117747645 | CMS |
| Dexcom, Inc. | $16.84 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153326015 | CMS |
| Lilly USA, LLC | $14.17 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135249183 | CMS |
| Lilly USA, LLC | $13.39 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135252989 | CMS |
| Novo Nordisk Inc | $18.89 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097132571 | CMS |
| Novo Nordisk Inc | $14.12 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096698140 | CMS |
| Novo Nordisk Inc | $13.27 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096907927 | CMS |
| Novo Nordisk Inc | $14.23 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096841493 | CMS |
| Radius Health, Inc. | $15.71 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089980564 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.